Innovative modifications of conventional treatments for actinic keratosis (AK) can help patients live with this chronic disease in more comfort and greater safety, and with potentially improved outcomes.
Dr. Neal Bhatia shares his perspective on Actinic Keratosis from his Controversies session at the 23rd World Congress for Dermatology: pros and cons on routine eradication, trending populations, and modalities of treatment. learn more.
Photodynamic therapy (PDT) provided a better chance of complete lesion clearance in the treatment of actinic keratoses (AKs) when compared to treatment with cyrotherapy, according to results of a recent study.
Field therapy in patients with multiple facial actinic keratoses (AKs) is important for preventing the development of new, clinically visible lesions and squamous cell carcinoma. Yet, for a number of reasons, including the need for prolonged topical treatment and poor tolerability, field therapy is widely underused.